Jang Bahadurgupta

Title: Jang Bahadurgupta: Innovator in Pharmaceutical Chemistry

Introduction

Jang Bahadurgupta is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work has the potential to impact various medical conditions, showcasing his innovative spirit and dedication to improving healthcare.

Latest Patents

Jang Bahadurgupta holds a patent for a compound titled 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka. This patent describes novel piperazine derivatives that are substituted on one nitrogen by an aromatic system and on the other nitrogen by (2,5-dioxopyrrolidin)-1-yl) alkanes or (2,6-dioxopiperidin-1-yl) alkanes. These compounds have been found to exhibit selective α1A adrenergic activity, making them useful for treating various disease conditions, such as peripheral vascular disease, congestive heart failure, hypertension, and especially benign prostatic hypertrophy. He has 1 patent to his name.

Career Highlights

Jang Bahadurgupta has built a successful career in the pharmaceutical industry. He is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate and contribute to the development of new therapeutic agents. His expertise in medicinal chemistry has positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Jang has collaborated with several talented individuals, including Nitya Anand and Neelima Sinha. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical research.

Conclusion

Jang Bahadurgupta is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for various medical conditions. His innovative contributions and collaborations highlight the importance of research and development in improving healthcare outcomes.